REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pharmesa S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pharmesa S.A. Profile Updated: September 08, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Pharmesa S.A. is an enterprise based in Ecuador. Its main office is in Guayaquil. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Pharmesa S.A. was incorporated on February 22, 2022. It currently has a total number of 3 (2024) employees. The company’s latest financial report indicates a net sales revenue increase of 177.85% in 2024. A growth of 55.28% was recorded in its total assets. The net profit margin of Pharmesa S.A. increased by 155.12% in 2024.

Headquarters
Calle Clemente Ballen, 1301
Guayaquil; Guayas;

Contact Details: Purchase the Pharmesa S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Pharmesa S.A. report to view the information.
Registered Capital:
Purchase the Pharmesa S.A. report to view the information.
Financial Auditors:
Purchase the Pharmesa S.A. report to view the information.
Incorporation Date:
February 22, 2022
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
80%
Purchase this report to view the information.
10%
Purchase this report to view the information.
5%
Purchase this report to view the information.
5%
Company Performance
Financial values in the chart are available after Pharmesa S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
177.85%▲
Total operating revenue
161.67%▲
Operating profit (EBIT)
-19.03%▼
EBITDA
-14.57%▼
Net Profit (Loss) for the Period
-22.29%▼
Total Assets
55.28%▲
Total Equity
-143.26%▼
Operating Profit Margin (ROS)
155.52%▲
Net Profit Margin
155.12%▲
Return on Equity (ROE)
-58.26%▼
Debt/Equity
0.02%▲
Quick Ratio
0.35%▲
Cash Ratio
-0.07%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo